BIPHASIC DISSOLUTION MODEL: NOVEL STRATEGY FOR DEVELOPING DISCRIMINATORY IN VIVO PREDICTIVE DISSOLUTION MODEL FOR BCS CLASS II DRUGS
Open Access
- 1 April 2022
- journal article
- review article
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Pharmacy and Pharmaceutical Sciences
- p. 20-27
Abstract
In vitro dissolution study should ideally be designed to predict in vivo performance precisely, providing key information on the bioavailability and establishing IVIVC. Development of discriminatory in vivo predictive dissolution model and the establishment of IVIVC is difficult to achieve with BCS Class 2 drugs as they exhibit variable absorption along the GI tract owing to pH-dependent solubility, especially for Classes IIa and IIb. In this context, the biphasic dissolution model is a powerful technique for investigating the interplay between dissolution, precipitation and partitioning of various poorly soluble molecules. The dissolution test medium comprising of immiscible aqueous and organic phases enables maintenance of sink conditions and easy quantification of poorly soluble drug partitioning into the organic phase. In the review, novel efforts have been taken to provide comprehensive information on challenges associated with the establishment of IVIVC for BCS Class II drugs, various approaches being adopted for developing discriminatory in vivo predictive dissolution model, significant outcomes of studies on biphasic dissolution model to predict the in vivo dissolution behaviour of BCS Class II drugs and the problems with the use of biphasic dissolution model including the status of FDA on the same.Keywords
This publication has 81 references indexed in Scilit:
- Overcoming sink limitations in dissolution testing: a review of traditional methods and the potential utility of biphasic systemsJournal of Pharmacy and Pharmacology, 2012
- Study on dissolution and absorption of four dosage forms of isosorbide mononitrate: Level A in vitro–in vivo correlationEuropean Journal of Pharmaceutics and Biopharmaceutics, 2011
- Bioequivalence of Oral Products and the Biopharmaceutics Classification System: Science, Regulation, and Public PolicyClinical Pharmacology & Therapeutics, 2011
- A biorelevant dissolution stress test device – background and experiencesExpert Opinion on Drug Delivery, 2010
- Application of a Biphasic Test for Characterization of In Vitro Drug Release of Immediate Release Formulations of Celecoxib and Its Relevance to In Vivo AbsorptionMolecular Pharmaceutics, 2010
- In Vitro-In Vivo Correlation (IVIVC) and Determining Drug Concentrations in Blood from Dissolution Testing – A Simple and Practical Approach~!2009-10-30~!2010-01-04~!2010-04-29~!The Open Drug Delivery Journal, 2010
- The Use of Biorelevant Dissolution Media to Forecast the In Vivo Performance of a DrugThe AAPS Journal, 2010
- Biopharmaceutical challenges associated with drugs with low aqueous solubility—The potential impact of lipid-based formulationsAdvanced Drug Delivery Reviews, 2008
- Comparison of Four Artificial Neural Network Software Programs Used to Predict the In Vitro Dissolution of Controlled-Release TabletsPharmaceutical Development and Technology, 2002
- An artificial stomach‐duodenum model for the in‐vitro evaluation of antacidsAlimentary Pharmacology & Therapeutics, 1992